Characterizing patients undergoing first ablation for atrial fibrillation in Occitanie Ouest
Medical and Sociological Characterization of the Population of Patients Admitted for a First Ablation of Atrial Fibrillation in the Occitanie Ouest Region
This study looks at the different medical and social factors that affect patients getting their first heart procedure for atrial fibrillation in the Occitanie Ouest region.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 2 sites (Toulouse and 1 other locations) |
| Trial ID | NCT06618833 on ClinicalTrials.gov |
What this trial studies
This study aims to observe and characterize the medical, sociological, economic, and territorial factors influencing patients who undergo their first ablation for atrial fibrillation in the Occitanie Ouest region. It will collect comprehensive medical data, global health elements using the PROMIS global questionnaire, and sociological information from patients admitted to two centers: the Pasteur clinic and the Toulouse University Hospital. The goal is to understand how non-medical determinants affect access to this treatment and the overall management of atrial fibrillation. This observational study seeks to fill gaps in existing data regarding the population characteristics and treatment accessibility.
Who should consider this trial
Good fit: Ideal candidates for this study are patients admitted for their first ablation of atrial fibrillation.
Not a fit: Patients under 18 years of age, pregnant individuals, or those without coverage by the French health system will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of the factors affecting access to atrial fibrillation ablation, potentially leading to better patient outcomes and resource allocation.
How similar studies have performed: While studies in other countries have explored similar themes, this approach is novel in the context of the Occitanie Ouest region.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted for first ablation of Atrial Fibrillation Exclusion Criteria: * Patients under 18 years of age * Pregnancy * No coverage by the French health system * Refusal to consent * History of left atrium ablation
Where this trial is running
Toulouse and 1 other locations
- Clinique Pasteur — Toulouse, France (Recruiting)
- Rangueil Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Alexandre DUPARC, MD — University Hospital, Toulouse
- Study coordinator: Alexandre DUPARC, MD
- Email: duparc.a@chu-toulouse.fr
- Phone: 0561323659
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.